XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Common Stock Held in Treasury
Cumulative Effect, Period of Adoption, Adjustment
Common Stock Held in Treasury
Cumulative Effect, Period of Adoption, Adjustment
Total
Balance at beginning of period at Jan. 31, 2021 $ 264 $ 448,417 $ (2,094) $ (271) $ 916,683   $ (27,029) $ (271) $ 1,336,241
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Equity awards exercised/vested, net   (5,026)         5,026    
Share-based compensation expense   8,419             8,419
Taxes paid for net share settlements   (4,334)             (4,334)
Other comprehensive income (loss), net     (4,932)           (4,932)
Net income (loss)         45,489       45,489
Balance at end of period at Jul. 31, 2021 264 447,476 (7,026)   961,901   (22,003)   1,380,612
Balance at beginning of period at Apr. 30, 2021 264 450,961 (9,057)   942,733   (27,025)   1,357,876
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Equity awards exercised/vested, net   (5,022)         5,022    
Share-based compensation expense   5,871             5,871
Taxes paid for net share settlements   (4,334)             (4,334)
Other comprehensive income (loss), net     2,031           2,031
Net income (loss)         19,168       19,168
Balance at end of period at Jul. 31, 2021 264 447,476 (7,026)   961,901   (22,003)   1,380,612
Balance at beginning of period at Jan. 31, 2022 264 456,329 (14,529)   1,117,005   (39,157)   1,519,912
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Equity awards exercised/vested, net   (10,163)         10,163    
Share-based compensation expense   25,245             25,245
Taxes paid for net share settlements   (9,790)             (9,790)
Other comprehensive income (loss), net     (1,697)           (1,697)
Repurchases of common stock             (16,622)   (16,622)
Net income (loss)         66,953       66,953
Balance at end of period at Jul. 31, 2022 264 461,621 (16,226)   1,183,958   (45,616)   1,584,001
Balance at beginning of period at Apr. 30, 2022 264 460,999 (18,657)   1,147,639 $ (16,622) (31,953) $ (16,622) 1,558,292
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Equity awards exercised/vested, net   (2,959)         2,959    
Share-based compensation expense   4,696             4,696
Taxes paid for net share settlements   (1,115)             (1,115)
Other comprehensive income (loss), net     2,431           2,431
Net income (loss)         36,319       36,319
Balance at end of period at Jul. 31, 2022 $ 264 $ 461,621 $ (16,226)   $ 1,183,958   $ (45,616)   $ 1,584,001